Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Changes in health-related quality of life in incipient stroke survivors].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2015
Same author

Stereoselective synthesis of 1,4-diols by a tandem allylboration-allenylboration sequence.

Organic letters·2015
Same author

The effect of lactic acid bacteria on cocoa bean fermentation.

International journal of food microbiology·2015
Same author

The performance of a combined nitritation-anammox reactor treating anaerobic digestion supernatant under various C/N ratios.

Journal of environmental sciences (China)·2015
Same author

Cytotoxicity profile of novel sterically hindered platinum(II) complexes with (1R,2R)-N(1),N(2)-dibutyl-1,2-diaminocyclohexane.

European journal of medicinal chemistry·2015
Same author

Functional Proteomics Study Reveals SUMOylation of TFII-I is Involved in Liver Cancer Cell Proliferation.

Journal of proteome research·2015

Related Experiment Video

Updated: May 18, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Nitric oxide donor-based platinum complexes as potential anticancer agents.

Jian Zhao1, Shaohua Gou, Yanyan Sun

  • 1Pharmaceutical Research Center, School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, PR China.

Chemistry (Weinheim an Der Bergstrasse, Germany)
|September 28, 2012
PubMed
Summary
This summary is machine-generated.

New platinum complexes with organic nitrate ligands show enhanced anticancer activity. This synergy combines nitric oxide release with platinum

More Related Videos

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Related Experiment Videos

Last Updated: May 18, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Area of Science:

  • Medicinal Chemistry
  • Inorganic Chemistry
  • Cancer Research

Background:

  • Platinum-based compounds are a cornerstone of cancer chemotherapy.
  • Carboplatin is a widely used platinum-based chemotherapy drug.
  • Nitric oxide (NO) plays a complex role in cancer biology, with potential therapeutic applications.

Purpose of the Study:

  • To synthesize and characterize novel platinum complexes incorporating organic nitrate ligands.
  • To evaluate the in vitro anticancer activity of these novel complexes.
  • To investigate the potential synergistic effects between platinum and nitric oxide release.

Main Methods:

  • Synthesis of platinum complexes with organic nitrate ligands.
  • Assessment of complex stability in aqueous solutions.
  • In vitro cytotoxicity assays against cancer cell lines.
  • Comparison of cytotoxicity with parent compounds like carboplatin.

Main Results:

  • The novel platinum-organic nitrate complexes demonstrated stability in aqueous solution.
  • These complexes exhibited superior cytotoxicity compared to the parent compound, carboplatin.
  • Evidence suggests a synergistic effect between the platinum moiety and nitric oxide release.

Conclusions:

  • Platinum complexes with organic nitrate ligands represent a promising class of anticancer agents.
  • The enhanced efficacy is attributed to a dual mechanism involving DNA inhibition and nitric oxide release.
  • These findings warrant further investigation for clinical development.